Chuck Schumer on CBO: Pot Calls Kettle Black
Posted by Larry Doyle on July 18th, 2009 9:05 AM |

Senator Charles Schumer (D-NY)
Who do you trust?
Is there any greater virtue than trust? In business, as in life, real differences of opinion are part and parcel of good, honest, and open debate. The premise for that debate is based upon trust. The challenge for the American public has long been deciphering the honest differences of opinion from questions of trust.
I see evidence of that once again in a Bloomberg interview with New York Senator Chuck Schumer (D-NY), Schumer Says CBO ‘Wacky’ on Health Costs, Sees Passage:
The Senate can pass legislation overhauling the U.S. health-care system by August with some Republican support even with the “wacky” cost estimates by the Congressional Budget Office, Senator Charles Schumer said.
Senate Finance Committee Chairman Max Baucus thinks his panel can draft a bill by July 21 or 22, Schumer, the No. 3 Democrat in the Senate, said in an interview with Bloomberg Television’s “Political Capital with Al Hunt,” airing today.
“Our preference far and away is for a bipartisan bill,” Schumer said. “If we can’t come to a bipartisan agreement, the Finance Committee will report out a Democratic bill.”
The New York senator said the CBO’s assessment that health-care costs would rise under legislation being considered by congressional Democrats doesn’t take into account savings from preventive care and efficiencies in the system.
“CBO’s scoring is a little bit wacky,” Schumer said of the nonpartisan agency’s estimates. “They are not quite fair because they don’t measure the cost savings down the road, just the immediate spending.”
What is the Congressional Budget Office? What is their mission? Read the rest »
RSS Feed
Twitter
Facebook
Email
Home
High frequency trading activity has become a very hot topic both on and off Wall Street. My trading instincts tell me that this activity is not productive for the long term health and well being of the market. I have referenced the work of Joe Saluzzi and his colleagues at Themis Trading in making the case for the prosecution.
What 3rd grade kid ever really enjoyed the multiplication tables? Every youth in Boston would race through those tables in order to get outside and play some street hockey, a much more stimulating experience!!
profits in the form of compensation.













Can We ‘TRACE’ JP Morgan’s Business?
Posted by Larry Doyle on July 17th, 2009 9:09 AM |
On Wall Street, information is everything!! Access to the information is invaluable. Why? Given the speed with which markets move, any early hint of developing news is priceless in terms of the ability to transact quickly and profitably.
Why is ‘high frequency program trading’ viewed with such skepticism? Select participants with advanced computer programs gain access to market flows prior to other participants and are able to act on it. That playing field is not level. I shared my disdain for this practice in writing, “Why High Frequency Program Trading Smells.”
What other battles are being waged by Wall Street firms looking to defend their turf at the expense of consumers and investors? Credit cards and credit derivatives. Which Wall Street firm has the greatest combined exposure to these businesses? None other than JP Morgan Chase.
The Financial Times highlights how JP Morgan Chief Hits at Credit Card Rules:
While Mr. Dimon is railing on new legislation aimed to protect consumer interests in the credit card space, he conveniently avoids mentioning how both JP Morgan Chase and Bank of America are already implementing procedures to skirt that legislation. How might these financial behemoths do that? Shift from fixed rate credit cards to variable rate. I exposed this maneuver a few weeks back in writing, “Banks Build Better Mousetrap.”
Dimon continues his defense of JP Morgan’s franchise:
In regard to derivatives activity, JP Morgan has a dominant position in the market. Why? Their strong capital position, enormous balance sheet, and strong credit rating make them an attractive counterparty for customers. Make no mistake, JP Morgan has a license to ‘print’ money, and a lot of it, across the entire derivatives platform.
While Washington will tout how they are increasing regulation of the derivatives space, this business is truly multi-pronged. There are plain vanilla derivatives in more highly liquid sectors of the market. These ‘standardized’ derivatives will most certainly move to an exchange to create total transparency. Value added for customers will be minimal only because these markets are already fairly well defined and exposed. JP Morgan and other Wall Street firms will cede this ‘standardized’ space while they fight tooth and nail to maintain their enormously advantageous position in the area of ‘customized’ derivatives.
There is little to no transparency in the world of customized derivatives and as a result the bid-ask spreads are very wide. Cha-ching, cha-ching. Jamie and his friends on Wall Street are working extremely hard to keep it this way.
In their defense, it is likely not functionally feasible to move many customized derivatives to an exchange. What should regulators compel them to do? JP Morgan and every other financial firm on Wall Street should have to report every derivatives transaction to a system known as TRACE, which stands for Trade Reporting and Compliance Engine. This system currently only covers transactions within the cash markets and not derivatives. What does that mean for investors? No transparency and price discovery for investors in the customized derivatives space. As such, Jamie and friends can keep those bid-ask spreads nice and wide and ring up huge profits in the process.
I won’t make many friends on Wall Street, and perhaps lose some of my current friends, but TRACE should be implemented across all product lines. For those involved in the markets, please access the TRACE system to gain a wealth of pricing data while keeping your brokers and financial planners honest!!
LD
Comments (2)